U.S. scientists invent new device for bacterial membrane detection

transverse analysis device, developed by faculty and students at the University of North Arizona and The State University of Maryland, detects biofilm-specific antibodies in patients by binding biofilm-specific proteins to antibodies, similar to detecting streptococcal infections in the throatThis will help medical personnel diagnose biofilm-infecteddiseases as early as possible
and implement effective treatmentMost of the time bacteria in the "microcloning" way, bacteria themselves in each "microclone" occupies less than one-third of the volume, the rest of the space is secreted by bacteria known as "extracellular matrix" of the viscose substances, this viscose substance will be thousands of bacteria micro-clones glued together to form a biological membraneAbout 70% of bacterial infections are caused by bacterial biofilmsBacterial biofilms are highly resistant to antibiotics and host immune defense mechanisms, once bacteria at the infected site form biofilms, even if the use of drugs hundreds of times the normal dose is not easy to cure, which is leading to chronic and difficult to treat infectiousdiseasesone of the important reasonsIn the U.S., the cost of treating such infectious diseases is about $5 billion a year, according to the Centers for Disease Control and Prevention"Previously, medical workers didn't have effective ways to diagnose these infectious diseases, delaying patient care, and now the problem is expected to be solved," said Jeff Reed of the Center for Microbiology Genetics at the University of North Arizona"At the moment, researchers are trying to negotiate the details of theof using theinstrument and are looking for companies interested in registering the technology to mass produce theinstrumentso that it can be widely used as amedical device